Free with code THANKSREDDIT good through ~Jan 4, 2026 Or subscribe here for PDFs of several books.

Milsaperidone (BYSANTI) is a second-generation antipsychotic recently approved for schizophrenia and mania as an equivalent to iloperidone (FANAPT) . Why Bysanti exists Year Vanda Pharmaceuticals 2009 Iloperidone ( FANAPT ) approved ~2027 Fanapt patents expire → generics expected 2026 Milsaperidone ( BYSANTI ) approved ~2044 Bysanti patent protection expected Milsaperidone (BYSANTI) is an active metabolite of iloperidone (FANAPT) but not like these: Parent drug Direct metabol

According to The Lithium Handbook (Meyer & Stahl 2023), the only medication that "should not be combined with lithium" is this ACE inhibitor.

PDF available to subscribers here To excel in psychopharmacology, one must master lithium. Patients with mood disorders do best when their provider manages lithium safely and effectively. Research consistently shows that appropriate use improves outcomes, reduces suicide risk, and may even prevent Alzheimer’s disease and extend healthy lifespan. This is a lithium-centric pharmacology book . Outside of The Lithium Handbook by Meyer & Stahl (2023), reliable prescribing inform